Reuters: Regulatory News: BRIEF-Janssen says received European commission approval for hepatitis C drug Incivo

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Janssen says received European commission approval for hepatitis C drug Incivo May 31st 2013, 08:36 LONDON | Fri May 31, 2013 4:36am EDT LONDON May 31 (Reuters) - Johnson & Johnson : * Janssen - incivo gets European commission approval for twice daily dosing for

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions